New research could improve current cancer treatments
Combining existing chemotherapy drugs with cancer treatments that cut off blood supply to a tumour could be more effective, new research from the University...
A new approach to the treatment of prostate cancer
By understanding the production of specific human sex hormones, it can help develop new treatments for prostate cancer and polycystic ovary syndrome, a new...
Heart doctors want to provide treatment for acute ischaemic stroke
Heart doctors from the European Society of Cardiology (ESC) Council on Stroke are calling on national authorities for permission to provide acute ischaemic stroke...
What is being done to support cancer survivors returning to work?
In light of the European Week Against Cancer, 25-31 May, the European Agency for Safety and Health at Work (EU-OSHA) has published recent findings...
Atopic eczema in adults linked to increased heart problems
Those with atopic eczema in adult life have an increased risk of cardiovascular problems, according to a new UK study published this week.
The study,...
Can antidepressants increase the risk of weight gain?
A new study published in The BMJ today has found that long term use of antidepressants is linked to the increase in risk of...
WHO and World Bank Group to strengthen global health security
The World Health Organization (WHO) and World Bank Group have today launched a new mechanism to strengthen global health security which will help tackle...
How depression can negatively affect cognitive function
People with depression or anxiety will have an increased risk of reduced cognitive function due to the advanced speed with which the brain ages,...
Two new lung cancer risk factors have been discovered
Seven risk factors, including two new ones, can help predict susceptibility to developing lung cancer and they don’t just apply to heavy smokers.
A new...
Mental Health Europe calls for equal rights at European elections
With one year until the next European elections, Mental Health Europe (MHE) has said that EU states must reform outdated laws which strip those...
How has the food industry done so far in the sugar reduction programme?
Public Health England (PHE) has published the first assessment of progress for the government’s sugar reduction programme, revealing how the food industry has done...
Traffic light food labelling influences UK public’s spending habits
The traffic light food labelling system is more likely to influence what eating establishment someone will choose to buy food from, according to a...
Uppsala Health Summit Report challenges cancer diagnosis and care
An Uppsala Health Summit Report has been published this week which focuses on how to encourage better and more equal access to the best...
A more active commute to work could reduce risk of heart disease
Avoiding the car and having a more physically active commute to work could reduce the risk of dying from heart disease and stroke by...
Interventional cardiology practice report presented at EuroPCR 2018
An interventional cardiology practice report was presented this week at EuroPCR 2018, the annual meeting of the European Association of Percutaneous Cardiovascular Interventions (EAPCI),...
An egg a day could reduce risk of cardiovascular disease
By consuming one egg every day it could help reduce the risk of cardiovascular disease (CVD), according to a new study carried out in...
Inflammatory bowel disease might help with Parkinson’s disease
A possible link between inflammatory bowel disease (IBD) and Parkinson’s disease which could help doctors to slow down the neurological condition has been described...
How artificial intelligence is vital in improving cancer care
Following UK Prime Minister Theresa May’s speech regarding artificial intelligence’s (AI) potential of saving thousands of lives by improving cancer care, experts have weighed...
Ebola vaccine being given to ‘high risk’ Democratic Republic of the Congo
With support of the WHO and partners, the Government of the Democratic Republic of Congo is preparing the Ebola vaccine for high risk populations...
European Commission approves single pill for HIV-1 treatment
The Janssen Pharmaceutical Companies of Johnson & Johnson have today announced that the European Commission has approved JULUCA® (dolutegravir/rilpivirine), a once daily single pill...